Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae

Journal of Clinical Microbiology

Volumn 50, Issue 9, 2012, Pages 3016-3022

  Nordmann, Patrice ^a   Dortet, Laurent ^a   Poirel, Laurent ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID; TAZOBACTAM;

ACCURACY; ACIDITY; ANALYTIC METHOD; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD CULTURE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENZYME ACTIVITY; ESBL NDP TEST; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE NORDMANN DORTET POIREL TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HYDROLYSIS; INCUBATION TIME; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEUS MIRABILIS; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CEPHALOSPORINS; COLOR; COSTS AND COST ANALYSIS; CULTURE MEDIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84865170351     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00859-12     Document Type: Article

References (13)

1. Bush K, Jacoby GA. 2010. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54:969-976. doi:10.1128/AAC.01009-09.
2. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 21st informational supplement M100-S22 (updated January 2012). CLSI, Wayne, PA.
3. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 13:pii=19044. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044.
4. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. 17 May 2012. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J. Antimicrob. Chemother. [Epub ahead of print.] doi:10.1093/jac/dks156.
5. Drieux L, Brossier F, Sougakoff W, Jarlier V. 2008. Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae; review and bench guide. Clin. Microbiol. Infect. 14(Suppl. 1):90-103. (Pubitemid 350269190)
6. Gazin M, et al. 2012. Current trends in culture-based and molecular detection of extended-spectrum β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol. 50:1140-1146.
7. Livermore DM, et al. 2007. CTX-Ms; changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. (Pubitemid 47072053)
8. Oteo J, Perez-Vazquez M, Campos J. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opinion Infect. Dis. 23:320-326.
9. Pitout JD, Laupland KB. 2008. Extended-spectrum β-lactamase- producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. (Pubitemid 351249250)
10. Poirel L, Bonnin R, Nordmann P. 2012. Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram negative rods. Infect. Genet. Evol. 12:883-893.
11. Réglier-Poupet H, et al. 2008. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum β-lactamases. J. Med. Microbiol. 57:310-315. (Pubitemid 351358533)
12. Schwaber MJ, et al. 2006. Clinical and economic impact of bacteremia with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 50:1257-1262. doi:10.1128/AAC.50.4.1257-1262.2006.
13. Zahar JR, et al. 2009. Addressing the challenge of extended-spectrum β-lactamases. Curr. Opin. Investig. Drugs 10:172-180.